Cover image of the article: IL-23 and IL-27 gene expression in three breast cancer cell lines and metastatic and non-metastatic lymph nodes in breast cancer patients

Image Credit:Koomesh

IL-23 and IL-27 gene expression in three breast cancer cell lines and metastatic and non-metastatic lymph nodes in breast cancer patients

Authors

Alireza Eskandari, Mansooreh JabariPor, Ali KhodadadiAli Khodadadi ORCID,*, Abbas Ghaderi
*Corresponding Author: Email: akhodadadi2@gmail.com

Koomesh:Vol. 12, issue 4; 428-434
Published online:May 25, 2011
Article type:Research Article
Received:Nov 06, 2010
Accepted:Feb 06, 2011
How to Cite:Eskandari A, JabariPor M, Khodadadi A, Ghaderi A. IL-23 and IL-27 gene expression in three breast cancer cell lines and metastatic and non-metastatic lymph nodes in breast cancer patients. koomesh. 2011;12(4):e152477. doi:

Abstract

  Introduction: There is a great need to identify prognostic and diagnostic cancer bio-markers which can be applied for vaccine and immunotherapy development. The aim of this study was to determine gene expression of IL-23 and IL-27 in two groups: lymph nodes of breast cancer patients and three cell lines.   Materials and Methods: IL-23 and IL-27 mRNA transcript were investigated in 10 lymph node samples (consisting of 5 metastasis and 5 non metastasis ones) and three cell lines (including of SKBR3, MDA-MB-468 and MCF7) by quantitative real time PCR (Q-PCR) procedure using designed primers, Master Mix reaction containing SYBER green and β actin housekeeping gene.   Results: Data showed no significant differences in IL-23 and IL-27 mRNA gene expressions among metastatic lymph node and non-metastatatic ones. Also, we did not find any significant differences in IL-23 and IL-27 mRNA expressions in cancer cell lines.   Conclusions: Our findings indicate that breast cancer microenvironment has no effect on inflammation via either IL-23 gene expression or Il-27.  

Highlights

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Sep
2017
The Role of Interleukin-8 and Its Mechanism in Patients with Breast Cancer: Its Relation with Oxidative Stress and Estrogen Receptor

The Role of Interleukin-8 and Its Mechanism in Patients with Breast Cancer: Its Relation with Oxidative Stress and Estrogen Receptor

Robab Sheikhpour

Sheikhpour R. The Role of Interleukin-8 and Its Mechanism in Patients with Breast Cancer: Its Relation with Oxidative Stress and Estrogen Receptor. Int J Cancer Manag. 2017;10(9):e8791. doi: https://doi.org/10.5812/ijcm.8791

4
Nov
2018
Association Study of rs763780T>C IL-17F and rs2275913G>A IL-17A Polymorphisms with Breast Cancer Risk in East Azerbaijan-Iran

Association Study of rs763780T>C IL-17F and rs2275913G>A IL-17A Polymorphisms with Breast Cancer Risk in East Azerbaijan-Iran

Elnaz Aghayi,
Nazila Moghtaran Bonab,
Zahra Hojjati Bonab

Aghayi E, Moghtaran Bonab N, Hojjati Bonab Z. Association Study of rs763780T>C IL-17F and rs2275913G>A IL-17A Polymorphisms with Breast Cancer Risk in East Azerbaijan-Iran. Gene Cell Tissue. 2018;5(3):e84483. doi: https://doi.org/10.5812/gct.84483

30
Apr
2017
miR-155 Expression in the Serum of Patients with Ductal Carcinoma in Situ (DCIS) of the Breast and Patients with Invasive Ductal Carcinoma (IDC) of the Breast

miR-155 Expression in the Serum of Patients with Ductal Carcinoma in Situ (DCIS) of the Breast and Patients with Invasive Ductal Carcinoma (IDC) of the Breast

Bentolhoda Shooshtarian,
Javad Mohammadi-asl,
Lila Kohan

Shooshtarian B, Mohammadi-asl J, Kohan L. miR-155 Expression in the Serum of Patients with Ductal Carcinoma in Situ (DCIS) of the Breast and Patients with Invasive Ductal Carcinoma (IDC) of the Breast. Jentashapir J Cell Mol Biol. 2017;8(2):e62563. doi: https://doi.org/10.5812/jjhr.62563

31
Dec
2014
The Effect of Interleukin 36 Gene Therapy in the Regression of Tumor

The Effect of Interleukin 36 Gene Therapy in the Regression of Tumor

Shiva Solahaye-Kahnamouii,
Farrokh Farhadi,
Mahni Rahkare-Farshi,
Farzaneh Pakdel,
Atabak Kashefimehr,
Firouz Pouralibaba
,et al.

Solahaye-Kahnamouii S, Farhadi F, Rahkare-Farshi M, Pakdel F, Kashefimehr A, et al. The Effect of Interleukin 36 Gene Therapy in the Regression of Tumor. Int J Cancer Manag. 2014;7(4):e80557. doi:

9
Feb
2022
Analysis of Blood and Tissue miR-191, miR-22, and EGFR mRNA as Novel Biomarkers for Breast Cancer Diagnosis

Analysis of Blood and Tissue miR-191, miR-22, and EGFR mRNA as Novel Biomarkers for Breast Cancer Diagnosis

Arezo Shahi,
Naghmeh Bahrami,
Robab Rafiei Tabatabaei,
Mehdi Kazempour Dizaji,
Hamidreza Jamaati,
Abdolreza Mohamadnia

Shahi A, Bahrami N, Rafiei Tabatabaei R, Kazempour Dizaji M, Jamaati H, et al. Analysis of Blood and Tissue miR-191, miR-22, and EGFR mRNA as Novel Biomarkers for Breast Cancer Diagnosis. Int J Cancer Manag. 2022;15(1):e117612. doi: https://doi.org/10.5812/ijcm.117612

More by these authors

Alireza EskandariPubMedScholar
Mansooreh JabariPorPubMedScholar
Ali KhodadadiPubMedScholar
Abbas GhaderiPubMedScholar
Share
Cited by
Metrics